APPIA

Appia is a Columbia University academic spin-out that employs a lean biotech model using certified contract organizations, academic collaborations and a team of expert consultants and financial officers... Our team is investigating a family of proprietary compounds that reverses abnormal epigenetic modifications found in certain cancer cells as well as cells undergoing neurodegenerative processes... Appia Pharmaceuticals was founded in 2014 and is a clinical stage drug development company focused on the development of drugs modulating gene transcription factors. Drugs are developed starting from a technology platform aimed at assessing acetylation of gene transcription factors

Primary location: Greenwich United States